NYSE - Delayed Quote USD
Johnson & Johnson (JNJ)
157.30
+2.83
+(1.83%)
At close: May 7 at 4:00:02 PM EDT
155.70
-1.60
(-1.02%)
After hours: May 7 at 7:58:35 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 18 | 18 | 23 | 22 |
| Avg. Estimate | 2.68 | 2.69 | 10.61 | 11.09 |
| Low Estimate | 2.56 | 2.54 | 10.5 | 10.65 |
| High Estimate | 2.99 | 2.83 | 10.7 | 11.56 |
| Year Ago EPS | 2.82 | 2.42 | 9.98 | 10.61 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 15 | 15 | 20 | 21 |
| Avg. Estimate | 22.85B | 23.1B | 91.35B | 94.98B |
| Low Estimate | 22.51B | 22.91B | 90.82B | 93.09B |
| High Estimate | 23.09B | 23.24B | 91.87B | 96.65B |
| Year Ago Sales | 22.45B | 22.47B | 88.82B | 91.35B |
| Sales Growth (year/est) | 1.78% | 2.80% | 2.85% | 3.98% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | 2.7 | 2.21 | 2.01 | 2.58 |
| EPS Actual | 2.82 | 2.42 | 2.04 | 2.77 |
| Difference | 0.12 | 0.21 | 0.03 | 0.19 |
| Surprise % | 4.31% | 9.71% | 1.38% | 7.38% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 2.68 | 2.69 | 10.61 | 11.09 |
| 7 Days Ago | 2.68 | 2.69 | 10.62 | 11.11 |
| 30 Days Ago | 2.72 | 2.71 | 10.58 | 11.12 |
| 60 Days Ago | 2.73 | 2.72 | 10.57 | 11.13 |
| 90 Days Ago | 2.73 | 2.71 | 10.55 | 11.11 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 4 | 6 | 1 | 1 |
| Up Last 30 Days | 2 | 4 | 12 | 8 |
| Down Last 7 Days | 10 | 8 | 1 | 2 |
| Down Last 30 Days | 12 | 10 | 5 | 9 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| JNJ | -4.96% | 11.06% | 6.28% | 4.59% |
| S&P 500 | 12.50% | 3.24% | 7.95% | 13.84% |
Upgrades & Downgrades
| Maintains | Barclays: Equal-Weight to Equal-Weight | 4/17/2025 |
| Maintains | Raymond James: Outperform to Outperform | 4/16/2025 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 4/16/2025 |
| Reiterates | RBC Capital: Outperform to Outperform | 4/16/2025 |
| Maintains | Raymond James: Outperform to Outperform | 4/14/2025 |
| Maintains | B of A Securities: Neutral to Neutral | 4/10/2025 |
Related Tickers
MRK Merck & Co., Inc.
79.12
+0.10%
ABBV AbbVie Inc.
188.09
+0.50%
PFE Pfizer Inc.
22.79
-0.39%
BMY Bristol-Myers Squibb Company
47.62
+0.11%
AMGN Amgen Inc.
275.84
+2.00%
LLY Eli Lilly and Company
776.72
+0.21%
NVO Novo Nordisk A/S
67.55
+1.90%
GILD Gilead Sciences, Inc.
98.90
+1.04%
OGN Organon & Co.
8.76
-4.05%
GSK GSK plc
37.17
-0.88%